ANI PHARMACEUTICALS, INC (ANIP) Shareholders’ equity 2016–2025
ANI PHARMACEUTICALS, INC (ANIP) shareholders’ equity at each fiscal year-end, per SEC filings.
$540.7MFY2025 · since FY2016: $169.6M → $540.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $540.7M | +33.9% |
| FY2024 | $403.7M | -6.7% |
| FY2023 | $432.7M | +38.0% |
| FY2022 | $313.7M | -6.0% |
| FY2021 | $333.9M | +70.6% |
| FY2020 | $195.7M | -8.0% |
| FY2019 | $212.8M | +7.9% |
| FY2018 | $197.3M | +12.9% |
| FY2017 | $174.8M | +3.0% |
| FY2016 | $169.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice